PTP1b是血管内皮细胞内皮细胞中血管内皮生长因子信号的生理调节者
Anthony A Lanahan1, Diana Lech1, Alexandre Dubrac1
1From the Yale Cardiovascular Research Center, Section of Cardiovascular Medicine, Department of Internal Medicine (A.A.L., D.L., A.D., J.Z., Z.W.Z., A.E., M.S.) and the Department of Cell Biology (M.S.), Yale University School of Medicine, New Haven, CT.
Circulation
|July 2, 2014
概括
酸酶 PTP1b 调节血管形成. 在内皮细胞中去除PTP1b可增强血管内皮生长因子受体-2 (VEGFR2) 信号传递,促进血管生成和动脉生成.
科学领域:
- 血管生物学 血管生物学
- 分子信号传递是分子信号传递.
- 再生医学是一种再生医学.
背景情况:
- 血管内皮生长因子受体-2 (VEGFR2) 信号控制血管树的形成.
- 内皮细胞贩运VEGFR2会影响其活动.
- 酸酶PTP1b (PTP1b) 涉及到VEGFR2的内皮贩运.
研究的目的:
- 定义PTP1b在内皮VEGFR2信号传递中的作用.
- 研究PTP1b在调节血管生成和动脉生成中的作用.
主要方法:
- 生成的小鼠具有内皮特异性删除PTP1b.
- 评估了体外和体外的VEGF信号传递,血管生成和动脉生成.
- 使用了视网膜血管生成,Matrigel植入物和后肢缺血模型.
主要成果:
- PTP1b淘汰的内皮细胞显示了VEGF依赖的信号传递,发芽,迁移和增殖的增加.
- 内皮PTP1b无细胞小鼠表现出增强的视网膜和Matrigel血管生成以及加速的伤口愈合.
- 在后肢缺血模型中观察到动脉发生率增加,血液流量恢复速度更快,新血管形成.
结论:
- PTP1b是内皮VEGFR2信号的关键调节者.
- PTP1b在控制血管树形成的程度方面发挥着重要作用.
更多相关视频
相关概念视频
Regulation of Angiogenesis and Blood Supply
2.9K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.9K
TGF - β Signaling Pathway
7.1K
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
7.1K
PI3K/mTOR/AKT Signaling Pathway
5.1K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
5.1K
mTOR Signaling and Cancer Progression
3.6K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.6K
Mechanism of Angiogenesis
6.3K
Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...
6.3K
Transducer Mechanism: Enzyme-Linked Receptors
4.4K
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
4.4K


